HormonalEmerging Evidence

Angiotensin 1-7

Also known as: Ang-(1-7), A(1-7)

Protective peptide of the renin-angiotensin system with vasodilatory and anti-inflammatory effects.

Evidence

Emerging

FDA status

Not FDA-approved

Source

Endogenous heptapeptide, can be synthesized

Overview

Protective peptide of the renin-angiotensin system with vasodilatory and anti-inflammatory effects.

Mechanism of Action

Binds Mas receptor (counterbalances ACE/Ang II pathway), vasodilation via NO/prostaglandin release, anti-fibrotic and anti-proliferative effects, reduces oxidative stress, anti-inflammatory via reduced cytokines, cardioprotective and neuroprotective actions.

What research has looked at

Effects reported in studies, not proven benefits. See the evidence section below for how strong the research is.

  • Heart and blood vessel effects (animal studies)
  • Vasodilation and blood pressure reduction
  • Anti-fibrotic effects
  • Neuroprotection
  • Anti-inflammatory
  • Metabolic benefits (improved insulin sensitivity)

Researched for

Research topics, not approved uses.

HypertensionHeart failureFibrotic diseasesMetabolic syndromeNeurodegenerative diseases

How Gabriel approaches peptides

Through Gabriel, licensed clinicians may prescribe BPC-157, TB-500, MOTS-c, epitalon and semax (nasal) as compounded medications from licensed 503A pharmacies, under HHS's October 28, 2026 interim policy, and only when appropriate. They are not FDA-approved, and Gabriel never gives peptide dosing. Angiotensin 1-7 isn't prescribed through Gabriel. If you're thinking about it, Gabriel can help you find a licensed clinician to look at the cause of what you're dealing with and the options with stronger evidence.

Read the peptide therapy guide

Research & Evidence

Evidence Level
Emerging
Studies

Preclinical studies, early clinical trials

Summary

Heart and metabolic effects are reported in animal studies. Human trials are early and small.

Safety Information

Potential Side Effects

  • •Unknown in humans (limited data)
  • •Theoretical hypotension

Contraindications

  • Under investigation

Interactions

  • ⚠May interact with ACE inhibitors and ARBs

Quick Facts

CategoryHormonal
SourceEndogenous heptapeptide, can be synthesized
StatusInvestigational, not approved